SEP 17·SEC EDGARLow
KERREY J ROBERT sold $3.2M of THC
KERREY J ROBERT sold 12,010 shares of TENET HEALTHCARE CORP (THC) at an average of $263.72 ($263.04–$264.62, $3.17M total) across 3 trades on 2026-09-14.
StockNYSE · US · USDHealthcare · Medical Care Facilities
$THC
TENET HEALTHCARE CORP
Price · $THCvia TradingView
AI sentiment · 7d2 articles
- Bullish
- 0
- Neutral
- 0
- Bearish
- 2
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $40.5M 12 txs
Sutaria Saumya5× · $27.6M
10b5-1 share of filings0%
Top stories · $THCMore →
SEP 15·investing.com
Why is Tenet Healthcare stock sliding today?
Tenet Healthcare (THC) shares fell 2.3% premarket after a director sold 10,000 shares at $263.42 each, totaling $2.63M. The company reported strong Q2 2026 earnings of $6.12 per share on $5.63B revenue, beating estimates. The broader market showed little movement. The stock remains within its 52-week range of $157.58 to $283.05.
SEP 15·SEC EDGAR
MARK RICHARD J sold $2.6M of THC
MARK RICHARD J sold 10,000 shares of TENET HEALTHCARE CORP (THC) at $263.42 ($2.63M total) on 2026-09-10.
THC sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning THC (TENET HEALTHCARE CORP). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.
Recent THC coverage spans insider activity, corporate actions and financial news.
In the last 30 days, THC insiders filed 12 SEC Form 4 transactions — no purchases and 12 sales ($40.5M). The most active reporter was Sutaria Saumya, CEO, with 5 filings.
What's driving THC
The insider sale may signal reduced confidence from a board member, potentially pressuring the stock short term.
The insider sale adds selling pressure and may weigh on the stock in pre‑market.
The insider sale may signal modest downside pressure but the amount is relatively small for a large cap.
The new unsecured notes push out near‑term maturities and increase total borrowings, potentially widening the yield spread and pressuring the stock.
The debt raise improves liquidity and reduces near‑term maturities, supporting the stock’s upside.
AlphAI scores every news story that mentions THC with an AI model for sentiment and relevance, and aggregates insider trades from TENET HEALTHCARE CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $THC
Score
KERREY J ROBERT sold $3.2M of THC
KERREY J ROBERT sold 12,010 shares of TENET HEALTHCARE CORP (THC) at an average of $263.72 ($263.04–$264.62, $3.17M total) across 3 trades on 2026-09-14.
1 min readWhy is Tenet Healthcare stock sliding today?
Tenet Healthcare (THC) shares fell 2.3% premarket after a director sold 10,000 shares at $263.42 each, totaling $2.63M. The company reported strong Q2 2026 earnings of $6.12 per share on $5.63B revenue, beating estimates. The broader market showed little movement. The stock remains within its 52-week range of $157.58 to $283.05.
1 min readMARK RICHARD J sold $2.6M of THC
MARK RICHARD J sold 10,000 shares of TENET HEALTHCARE CORP (THC) at $263.42 ($2.63M total) on 2026-09-10.
1 min readWhat Tenet Healthcare (THC)'s $2b Debt Refinance Means For Shareholders
Tenet Healthcare (THC) priced a $2.0 billion private placement of 6.250% senior notes due 2034, upsized from $1.5 billion, to refinance existing 2027 and 2028 debt. The refinancing replaces secured and partly secured borrowings with unsecured notes, altering the company's debt structure. Investors focus on execution, pricing, and free cash flow, with high debt and earnings declines noted as risks.
2 min read
Tenet Healthcare rises as refinancing plan and upbeat conference messaging lift sentiment
Tenet Healthcare (THC) shares rose 4.1% after upsizing a $2.0B senior notes offering and presenting at a healthcare conference. Management highlighted growth in higher-acuity services and cost discipline. The company plans to use proceeds to redeem 2027 and 2028 notes, simplifying near-term maturities. Analysts have set a median price target of $234.5.
2 min readTenet Healthcare at Wells Fargo conference: high-acuity push deepens
Tenet Healthcare (THC) presented at the Wells Fargo Healthcare Conference, outlining a strategy focused on high-acuity care, capital spending, and cost control. The company raised full-year guidance, citing volume growth and cost discipline. Shares are near their 52-week high at $268.82, up over 30% year-to-date. Tenet expects continued pressure in some payer channels and near-term earnings drag from Conifer's transition. Management plans to invest in complex procedures and maintain capital spen
2 min readTenet Healthcare Prices Upsized $2 Billion Notes Offering
Tenet Healthcare priced an upsized $2 billion notes offering, increasing from an initial $1.5 billion plan. The notes are senior and due in 2034. The company's stock has seen a 30.36% increase year-to-date. This move may impact the company's financial flexibility and investor sentiment.
1 min readBlackRock controls millions of Tenet Healthcare (NYSE: THC) shares, but how much voting power is solely its own?
BlackRock, Inc. owns 8,083,830 shares of Tenet Healthcare (THC), representing 10.0% of its common stock. BlackRock has sole voting power over 7,837,557 shares and sole dispositive power over all 8,083,830 shares, according to an amended Schedule 13G filing.
1 min readWest Nadja sold $298K of THC
West Nadja sold 1,152 shares of TENET HEALTHCARE CORP (THC) at $258.80 ($0.30M total) on 2026-09-02.
1 min readFoo Lisa Y sold $6.4M of THC
Foo Lisa Y (EVP, Chief Operating Officer) sold 24,000 shares of TENET HEALTHCARE CORP (THC) at $266.32 ($6.39M total) on 2026-08-31.
1 min read